Table 3.
1st inj.: MeNZB+MenC (N=38), MeNZB (N=19); 2nd inj.: MeNZB+MenC (N=36), MeNZB (N=19); 3rd inj.: MeNZB+MenC (N=35), MeNZB (N=18).
Subjects in the MeNZB+MenC group received MeNZB only at the 1st and 3rd dose.
1st inj.: MeNZB+MenC (N=38), MeNZB (N=19); 2nd inj.: MeNZB+MenC (N=36), MeNZB (N=19); 3rd inj.: MeNZB+MenC (N=35), MeNZB (N=18).
Subjects in the MeNZB+MenC group received MeNZB only at the 1st and 3rd dose.